Skip to content
Medical Health Aged Care

Low FODMAP diet can ease symptoms of those with endometriosis: study

Monash University 3 mins read

A low FODMAP diet developed by Monash University researchers for irritable bowel syndrome (IBS) has been shown to improve gastrointestinal symptoms in women with endometriosis.  

Sixty percent of study participants responded to the Low FODMAP Diet (LFD), compared to 26 per cent who responded to a control diet based on Australian Dietary Guidelines. 

The majority of those on the LFD experienced a clinically significant improvement in gastrointestinal symptoms, and overall symptom severity was 40 per cent lower on the LFD than on the control diet.


Published in Alimentary Pharmacology and Therapeutics, researchers found that the LFD also eased abdominal pain and bloating, and normalised stool consistency.

Dr Jane Varney, a Senior Research Dietitian in Monash University's School of Translational Medicine Department of Gastroenterology, and Alfred Health, said this research showed for the first time that the Low FODMAP Diet reduced gastrointestinal symptom severity in women with endometriosis.

Dr Varney said more than 75 per cent of women with endometriosis experienced gastrointestinal symptoms, which mimic those experienced by people with IBS. She said that while many women with endometriosis attempted to modify their diet to help manage their symptoms, until now there was limited evidence to suggest any particular dietary approach worked.

“Six out of 10 patients responded to the Low FODMAP Diet and reported clinically significant improvements in gastrointestinal symptoms,” Dr Varney said.

“Abdominal pain and bloating improved, stool form normalised and quality of life improved. Given the high prevalence of gastrointestinal symptoms among women with endometriosis, and the absence of targeted treatments, this study highlights a diet therapy that will bring symptom relief to many women.”

Developed in the mid-2000s, The Monash University Low FODMAP Diet revolutionised IBS treatment. Monash dietitians, scientists and gastroenterologists established the FODMAP diet’s effectiveness then released the FODMAP Diet App in 2012 and a cookbook in 2023.

This study involved 35 women aged over 18 with diagnosed endometriosis and gastrointestinal symptoms such as abdominal pain, bloating, altered bowel habits and pain during/after bowel movements.

After eating their usual diet for seven days, participants were randomised to one of two diets that were supplied by the researchers for 28 days. Both diets were based on Australian Healthy Eating Guidelines, but only one was low in FODMAPs. Participants then returned to their regular diet for 28 days, before crossing over to the alternate dietary intervention. The two study diets were matched for macronutrients, micronutrients and fibre, so they only differed in FODMAP content.

Senior author Associate Professor Rebecca Burgell, who is Head of the Functional Gut Service at Alfred Health, and an Adjunct Associate Professor at the Monash University School of Translational Medicine, said that despite the high prevalence of gastrointestinal symptoms in endometriosis, few treatments specifically targeted those symptoms, and some made them worse.

“Gastrointestinal symptoms associated with endometriosis are largely ignored in clinical guidelines,” Associate Professor Burgell said. “Most endometriosis guidelines fail to mention gastrointestinal symptoms and none offer advice about identification or management. Nor do IBS guidelines mention screening for endometriosis.”

What is endometriosis?

Endometriosis affects 1 in 7 Australian women. It occurs when body tissue lining the uterus (the endometrium) grows in other parts of the body. It usually grows in the pelvis but can occur in almost any part of the body. The tissue responds to the hormone oestrogen released from the ovaries. Although the cause of endometriosis is not known, one theory is that it may be caused by the backwards flow of menstrual fluid through the fallopian tubes and into the pelvis where it attaches and grows. This can cause inflammation, scarring and the formation of ‘sticky’ adhesions that bind pelvic organs together. As a result, normal bodily functions such as ovulating, having sex, and going to the toilet can become extremely painful, and fertility can be compromised.
Source: https://www.healthdirect.gov.au/endometriosis#what 


What are FODMAPs?

FODMAP stands for Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols. This group of carbohydrates is not completely digested or absorbed in the intestines. When FODMAPs reach the small intestine, they move slowly, attracting water. When they pass into the large intestine, they are fermented by gut bacteria, producing gas. The extra gas and water cause the intestinal wall to stretch and expand. 


A case study is available on request

For media enquiries please contact: Monash University


Cheryl Critchley – Media and Communications Manager (medical)

E: [email protected] 

T: +61 (0) 477 571 442

For more Monash media stories, visit our news and events site  

 

Helena Powell – Media Advisor (11am-12 noon and 2-4pm)

M: +61 (0) 474 444 171

E: [email protected] 


For general media enquiries please contact:
Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

 

***ENDS***

More from this category

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:
  • Medical Health Aged Care
  • 06/03/2026
  • 12:06
Royal Australian College of GPs

TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP

The Royal Australian College of GPs (RACGP) has expressed disappointment that the Victorian Government has overridden repeated warnings from the Therapeutic Goods Administration (TGA) by allowing pharmacists to prescribe the contraceptive pill, undermining established medicines safety safeguards. The Victorian Government has, contrary to repeated TGA assessments, weakened its medicines safety regulations by enabling pharmacists, rather than medically trained prescribers, to initiate prescriptions for the oral contraceptive pill. RACGP Victoria Chair Dr Anita Muñoz said the announcement prioritises political expediency and industry lobbying over evidence‑based public health. “We are deeply disappointed that the Victorian Government appears to be listening to lobbyists…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.